Latest news on Laboratorytalk categorised by product type
Antibodies
Archive page 8 of 8
Our RSS feed for Antibodies press releases
Further patent for LentiViral gene therapy
Oxford BioMedica has received allowance from the US Patent Office for a further patent covering its proprietary LentiVector technology
News from Oxford BioMedica (14 August 2003)
Improved yields of monoclonal antibodies
Laboratories producing monoclonal antibodies for numerous biological applications using tissue culture flasks or roller bottles are set to benefit from this development Brochure available
News from Integra Biosciences (10 July 2003)
Positive results from MetXia breast cancer trial
Oxford BioMedica announced encouraging results from its ongoing Phase I/II trial with MetXia in breast cancer patients
News from Oxford BioMedica ( 4 July 2003)
Manufacturing process for Parkinson's drug
Technical background article First discussion of the novel production approach used for ProSavin, a LentiVector-based product, to be made at Bio 2003 this week in Washington DC.
News from Oxford BioMedica (25 June 2003)
TroVax passes key regulatory hurdle in the USA
Oxford BioMedica's TroVax Receives Clearance from the United States Recombinant DNA Advisory Committee to Enter a Clinical Trial for Renal Cancer
News from Oxford BioMedica (21 May 2003)
An alternative to antibody production in mice
Hollow fibre in-vitro cell cultivation system offers production of monoclonal antibodies and expression of cell products over a period of months, avoiding the need for laboratory animals Brochure available
News from Integra Biosciences (20 May 2003)
Preclinical results from the RetinoStat
Oxford BioMedica and Institute of Ophthalmology describe key features of vision-loss product RetinoStat at the 2003 Annual Meeting of the Association for Research in Vision and Ophthalmology (Arvo)
News from Oxford BioMedica ( 7 May 2003)
European therapeutic monoclonal antibodies market
High specificity boosts prospects of Mabs, but price issues keep market on the back foot, says consultant's report
News from Frost and Sullivan ( 7 April 2003)
Genetic vector technology licenced
May prove key to development of avian transgenic technology as a novel platform for the efficient, cost-effective manufacturing of protein drugs
News from Oxford BioMedica (21 March 2003)
Colorectal cancer drug gets Phase II go-ahead
Product is based on a gene that encodes a protein, known as 5T4, which exists only on the surface of tumour cells and not on normal cells
News from Oxford BioMedica (13 March 2003)
Wyeth exercises option on anti-tumour antibody
Antibody is directed against a novel proprietary tumour-associated antigen that is expressed on a wide range of solid tumours
News from Oxford BioMedica (11 March 2003)
Ethical approval for TroVax trial
Oxford BioMedica has received ethical approval from the UK Gene Therapy Advisory Committee for TroVax to enter a Phase II clinical trial in patients receiving chemotherapy for colorectal cancer
News from Oxford BioMedica ( 4 March 2003)
Affinity purified anti-ATM protein kinase
A series of phospho specific antibodies to ATM protein kinase, the gene mutated in the hereditary disease ataxia-telangiectasia
News from Rockland Immunochemicals (11 February 2003)
New antibodies for transcription research
For use in the detection and identification of nuclear factor kappa B, they are ideal for use in western blotting, immunoprecipitation and immunohistochemistry
News from Cambridge BioScience (28 January 2003)
New labelling kit for polyclonal Rabbit antibodies
Molecular Probes' Zenon technology has revolutionised the fluorescent labelling of monoclonal Mouse antibodies, and it's now offered for use with polyclonal Rabbit antibodies
News from Cambridge BioScience (15 January 2003)
Antibodies optimised for automated immunostainers
Cambridge BioScience is launching a new range of Zymed antibodies which are optimised for use with the Ventana, DAKO and BioGenex automated staining platforms.
News from Cambridge BioScience (24 December 2002)
Paired monoclonal antibodies
Each monoclonal antibody is qualified to be part of a cooperative pair, anmd in many cases specific assay information is available to speed assay development Brochure available
News from OEM Concepts (17 September 2002)
Polyclonal production facility
Harlan Sera-Lab has completed its new polyclonal unit, with capacity for over 900 rabbits
News from Harlan Sera-lab (16 July 2001)
Guinea-pig polyclonal antibody to nicastrin
Immunohistochemical analysis reveals that nicastrin is localised to neurons known to be affected by Alzheimer's; Chemicon announces its new guinea-pig polyclonal antibody
News from Chemicon International (11 July 2001)
Monoclonal antibody production
Monoclonal antibody production Immunochemicals has just completed a 15,000-sqft laboratory expansion to support its custom monoclonal antibody development programme
News from Rockland Immunochemicals (10 July 2001)
Latest news from this category...
